First Time Loading...

Zymeworks Inc
NYSE:ZYME

Watchlist Manager
Zymeworks Inc Logo
Zymeworks Inc
NYSE:ZYME
Watchlist
Price: 8.26 USD 1.85%
Updated: Apr 29, 2024

Zymeworks Inc
Operating Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Zymeworks Inc
Operating Income Peer Comparison

Comparables:
RPTX
FUSN
AUPH
EDT
SBFM

Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
Zymeworks Inc
NYSE:ZYME
Operating Income
-$138.1m
CAGR 3-Years
10%
CAGR 5-Years
-33%
CAGR 10-Years
N/A
Repare Therapeutics Inc
NASDAQ:RPTX
Operating Income
-$116.2m
CAGR 3-Years
-30%
CAGR 5-Years
-55%
CAGR 10-Years
N/A
Fusion Pharmaceuticals Inc
NASDAQ:FUSN
Operating Income
-$99.2m
CAGR 3-Years
-38%
CAGR 5-Years
-58%
CAGR 10-Years
N/A
Aurinia Pharmaceuticals Inc
NASDAQ:AUPH
Operating Income
-$91.7m
CAGR 3-Years
4%
CAGR 5-Years
-10%
CAGR 10-Years
-36%
Spectral Medical Inc
TSX:EDT
Operating Income
-CA$11.7m
CAGR 3-Years
-9%
CAGR 5-Years
-38%
CAGR 10-Years
0%
Sunshine Biopharma Inc
OTC:SBFM
Operating Income
-$4.8m
CAGR 3-Years
-102%
CAGR 5-Years
-35%
CAGR 10-Years
-10%

See Also

What is Zymeworks Inc's Operating Income?
Operating Income
-138.1m USD

Based on the financial report for Dec 31, 2023, Zymeworks Inc's Operating Income amounts to -138.1m USD.

What is Zymeworks Inc's Operating Income growth rate?
Operating Income CAGR 5Y
-33%

The average annual Operating Income growth rates for Zymeworks Inc have been 10% over the past three years , -33% over the past five years .